Showing results (1271-1280 of 1,367) with videos related to

Sort By:
Pageof 137
The Journal of Infectious Diseases|March 14, 1998
Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in IcelandB A Perkins, K Jonsdottir, H Briem, et al.
Eclinicalmedicine|August 2, 2024
Long-term efficacy and safety of continued complement C1s inhibition with sutimlimab in cold agglutinin disease: CADENZA study Part BAlexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Schizophrenia Bulletin|April 1, 2020
Neural Circuitry of Novelty Salience Processing in Psychosis Risk: Association With Clinical OutcomeGemma Modinos, Paul Allen, Andre Zugman, et al.
Epilepsy & Behavior : E&B|June 3, 2017
A randomized controlled trial of a manual-based psychosocial group intervention for young people with epilepsy [PIE]Liam Dorris, Helen Broome, Margaret Wilson, et al.
American Journal of Hematology|April 6, 2026
Efficacy and Safety of Subcutaneous Efgartigimod PH20 in Adults With Primary Immune Thrombocytopenia (ADVANCE SC): A Multicenter, Randomized, Double-Blinded, Placebo-Controlled, Phase 3 TrialNichola Cooper, Catherine M Broome, Yoshitaka Miyakawa, et al.
Nature Cancer|June 10, 2021
An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemiaJeevisha Bajaj, Michael Hamilton, Yutaka Shima, et al.
BMC Psychiatry|July 2, 2025
Cognitive behavioural therapy in comparison to treatment as usual in young adults at high risk of developing bipolar disorder (Bipolar At Risk): a randomised controlled trial to investigate the efficacy of a treatment approach targeted at key appraisal change: Bipolar At Risk Trial II (BART II)Sophie Parker, Lydia Pearson, Rebekah Carney, et al.
Blood|June 10, 2022
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trialAlexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Nature Aging|April 28, 2023
Dietary supplementation of clinically utilized PI3K p110α inhibitor extends the lifespan of male and female miceC P Hedges, B Shetty, S C Broome, et al.
Pediatric Blood & Cancer|August 11, 2018
Baseline characteristics and outcomes of children with cancer in the English-speaking Caribbean: A multinational retrospective cohortT N Gibson, S Beeput, J Gaspard, et al.
Pageof 137